Simultaneous quantification of alprazolam, 4- and alpha-hydroxyalprazolam in plasma samples using liquid chromatography mass spectrometry

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jan 5;814(1):127-31. doi: 10.1016/j.jchromb.2004.10.012.

Abstract

A sensitive and specific method was developed for quantification of alprazolam and its two metabolites 4-hydroxyalprazolam and alpha-hydroxyalprazolam in plasma. The work up procedure was solid phase extraction. Liquid chromatography-mass spectrometry (LC-MS) was used for separation, detection and quantification of the analytes. The limit of quantitation (LOQ) was 0.05 ng/mL for alprazolam and the two metabolites. The extraction recovery was more than 82% for alprazolam and its metabolites. The within- and between-assay coefficients of variation were in the range of 1.9-17.9%. The method was used for determination of the pharmacokinetics parameters of alprazolam and its two metabolites in healthy Caucasian subjects who ingested 1mg of alprazolam.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alprazolam / analogs & derivatives*
  • Alprazolam / blood*
  • Alprazolam / pharmacokinetics
  • Anti-Anxiety Agents / blood*
  • Anti-Anxiety Agents / pharmacokinetics
  • Humans
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Anti-Anxiety Agents
  • alpha-hydroxyalprazolam
  • Alprazolam